1. Allergan, Inc. (134 from 2,285 patents)

2. Exonhit Therapeutics, Sa (12 from 25 patents)

3. Allergan Sales, Inc. (1 from 228 patents)

4. Allegran, Inc. (1 from 1 patent)

5. Bhat, Smita (0 patent)

6. Garst, Michael E. (0 patent)

7. Beard, Richard L. (0 patent)

8. Chow, Ken (0 patent)

9. Donello, John E. (0 patent)

10. Sinha, Santosh C. (0 patent)

1. 11331306 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

2. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

3. 11046644 - Sulfur derivatives as chemokine receptor modulators

4. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

5. 10899780 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

6. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

7. 10555933 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases

8. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

9. 10287243 - Sulfur derivatives as chemokine receptor modulators

10. 10251865 - Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

11. 10208071 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

12. 10201535 - Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

13. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

14. 10123988 - Compositions including encapsulated isotretinoin and methods for use thereof

15. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators